array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(29) "Regeneron Pharmaceuticals Inc"
["slug"]=>
string(38) "c469a-us-regeneron-pharmaceuticals-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/b5187988-884a-43b7-980d-e1555548ab77"
["description"]=>
string(868) "At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in.
Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media.
An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media. "
["address_street"]=>
string(25) "777 Old Saw Mill River Rd"
["address_place"]=>
string(9) "Tarrytown"
["address_region"]=>
string(8) "New York"
["founding_date"]=>
string(10) "1988-02-08"
["website_domain"]=>
string(13) "regeneron.com"
["website_url"]=>
string(25) "https://www.regeneron.com"
["industry_codes"]=>
array(1) {
[0]=>
string(27) "Pharmaceutical Preparations"
}
["employee_count"]=>
int(10368)
["article_count"]=>
int(2419)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(40) "REGENERON - Where are new opportunities?"
["snippet_en"]=>
string(121) "Regeneron shares have been under pressure for several weeks. How does this downward movement fit into the bigger picture?"
["url"]=>
string(70) "https://stock3.com/news/regeneron-wo-bieten-sich-neue-chancen-14484856"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/b2e49775-85a2-4761-b202-0f94c423d8ec"
["source"]=>
string(10) "stock3.com"
["publication_date"]=>
string(10) "2024-04-16"
["categories"]=>
array(1) {
[0]=>
string(12) "Stock Market"
}
}
[1]=>
array(7) {
["title_en"]=>
string(99) "Regeneron Ventures Launches with $500 Million Commitment to Fuel Promising Biotechnology Innovation"
["snippet_en"]=>
string(259) "GlobeNewswire, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public."
["url"]=>
string(128) "https://forextv.com/top-news/regeneron-ventures-launches-with-500-million-commitment-to-fuel-promising-biotechnology-innovation/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/88faab35-f2ba-421b-aa37-a5f507f9db9f"
["source"]=>
string(11) "forextv.com"
["publication_date"]=>
string(10) "2024-04-15"
["categories"]=>
array(2) {
[0]=>
string(14) "Product Launch"
[1]=>
string(18) "General Investment"
}
}
[2]=>
array(7) {
["title_en"]=>
string(75) "The week in pharma: action, reaction and insight – week to April 12, 2024"
["snippet_en"]=>
string(75) "The week in pharma: action, reaction and insight – week to April 12, 2024"
["url"]=>
string(108) "https://www.thepharmaletter.com/article/the-week-in-pharma-action-reaction-and-insight-week-to-april-12-2024"
["image_url"]=>
NULL
["source"]=>
string(19) "thepharmaletter.com"
["publication_date"]=>
string(10) "2024-04-14"
["categories"]=>
array(2) {
[0]=>
string(10) "Complaints"
[1]=>
string(5) "Legal"
}
}
[3]=>
array(7) {
["title_en"]=>
string(63) "US Intensifies Drug Discount Debate in Latest Regeneron Lawsuit"
["snippet_en"]=>
string(218) "New Justice Department allegations that Regeneron Pharmaceuticals Inc. artificially inflated Medicare reimbursement rates on a high-earning eye treatment are likely to trigger copycat complaints at other manufacturers."
["url"]=>
string(105) "https://news.bloomberglaw.com/us-law-week/us-intensifies-drug-discount-debate-in-latest-regeneron-lawsuit"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/435ec56d-4f91-4384-b5ae-96baa87ad0ff"
["source"]=>
string(16) "bloomberglaw.com"
["publication_date"]=>
string(10) "2024-04-12"
["categories"]=>
array(4) {
[0]=>
string(12) "Slash Prices"
[1]=>
string(31) "Financial Update/Profit Warning"
[2]=>
string(11) "US Politics"
[3]=>
string(5) "Legal"
}
}
[4]=>
array(7) {
["title_en"]=>
string(94) "RBC sees buying opportunity following Regeneron’s ‘overdone DOJ downside’ - TipRanks.com"
["snippet_en"]=>
string(167) "RBC Capital notes that the Department of Justice has filed a complaint against Regeneron, accusing the company of fraudulently inflating Medicare reimbursement rate..."
["url"]=>
string(108) "https://www.tipranks.com/news/the-fly/rbc-sees-buying-opportunity-following-regenerons-overdone-doj-downside"
["image_url"]=>
NULL
["source"]=>
string(12) "tipranks.com"
["publication_date"]=>
string(10) "2024-04-11"
["categories"]=>
array(2) {
[0]=>
string(10) "Complaints"
[1]=>
string(10) "Litigation"
}
}
[5]=>
array(7) {
["title_en"]=>
string(62) "Westport-based Abbvie to contest Inter-firms All-Ireland final"
["snippet_en"]=>
string(89) "Familiar Mayo club footballers to represent Abbvie in clash with Limerick-based Regeneron"
["url"]=>
string(107) "http://www.mayonews.ie/news/gaa/1473238/westport-based-abbvie-to-contest-inter-firms-all-ireland-final.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/4416ec08-1b67-4938-a975-b3e69f167a08"
["source"]=>
string(11) "mayonews.ie"
["publication_date"]=>
string(10) "2024-04-11"
["categories"]=>
array(0) {
}
}
[6]=>
array(7) {
["title_en"]=>
string(24) "Positive American market"
["snippet_en"]=>
string(52) "Analysts rule out a first interest rate cut in June."
["url"]=>
string(76) "https://www.teleborsa.it/News/2024/04/11/mercato-americano-positivo-215.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/ffa1e261-4820-40fe-b63f-f6d97e813802"
["source"]=>
string(12) "teleborsa.it"
["publication_date"]=>
string(10) "2024-04-11"
["categories"]=>
array(1) {
[0]=>
string(15) "Market Movement"
}
}
[7]=>
array(7) {
["title_en"]=>
string(90) "Regeneron Stock Under Microscope After DOJ Price Reporting Complaint—Key Levels to Watch"
["snippet_en"]=>
string(169) "Regeneron shares were lower in premarket trading Thursday after the DOJ filed a complaint accusing the drugmaker of fraudulent price reporting. Monitor these key levels."
["url"]=>
string(105) "https://www.investopedia.com/regeneron-stock-under-microscope-after-doj-price-reporting-complaint-8629923"
["image_url"]=>
NULL
["source"]=>
string(16) "investopedia.com"
["publication_date"]=>
string(10) "2024-04-11"
["categories"]=>
array(3) {
[0]=>
string(5) "Fraud"
[1]=>
string(24) "Stock Research & Ratings"
[2]=>
string(12) "Stock Market"
}
}
[8]=>
array(7) {
["title_en"]=>
string(54) "DoJ files False Claims Act complaint against Regeneron"
["snippet_en"]=>
string(54) "DoJ files False Claims Act complaint against Regeneron"
["url"]=>
string(94) "https://www.thepharmaletter.com/article/doj-files-false-claims-act-complaint-against-regeneron"
["image_url"]=>
NULL
["source"]=>
string(19) "thepharmaletter.com"
["publication_date"]=>
string(10) "2024-04-11"
["categories"]=>
array(1) {
[0]=>
string(10) "Complaints"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(196)
}
[1]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(192)
}
[2]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(149)
}
[3]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(98)
}
[4]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(95)
}
[5]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(82)
}
[6]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(68)
}
[7]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(60)
}
[8]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(50)
}
[9]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(48)
}
[10]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(45)
}
[11]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(42)
}
[12]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(35)
}
[13]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(34)
}
[14]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(34)
}
[15]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(33)
}
[16]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(33)
}
[17]=>
array(2) {
["name"]=>
string(14) "Product Review"
["count"]=>
int(32)
}
[18]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(31)
}
[19]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(31)
}
[20]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(29)
}
[21]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(29)
}
[22]=>
array(2) {
["name"]=>
string(8) "Verdicts"
["count"]=>
int(29)
}
[23]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(27)
}
[24]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(26)
}
[25]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(26)
}
[26]=>
array(2) {
["name"]=>
string(13) "Data Security"
["count"]=>
int(24)
}
[27]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(23)
}
[28]=>
array(2) {
["name"]=>
string(11) "Sponsorship"
["count"]=>
int(20)
}
[29]=>
array(2) {
["name"]=>
string(8) "Politics"
["count"]=>
int(20)
}
}
}
c469a-us-regeneron-pharmaceuticals-inc
Regeneron Pharmaceuticals Inc
Location
New York
Founded
1988-02-08
Website
https://www.regeneron.com
Articles
2419 Articles
Category
Pharmaceutical Preparations
Description
At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in.
Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media.
An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media.
GlobeNewswire, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
New Justice Department allegations that Regeneron Pharmaceuticals Inc. artificially inflated Medicare reimbursement rates on a high-earning eye treatment are likely to trigger copycat complaints at other manufacturers.
RBC Capital notes that the Department of Justice has filed a complaint against Regeneron, accusing the company of fraudulently inflating Medicare reimbursement rate...
Regeneron shares were lower in premarket trading Thursday after the DOJ filed a complaint accusing the drugmaker of fraudulent price reporting. Monitor these key levels.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
